Myoferlin, a candidate gene and potential modifier of muscular dystrophy von DAVIS, D. B, DELMONTE, A. J, LY, C. T, MCNALLY, E. M

Volltext

Calcium-sensitive Phospholipid Binding Properties of Normal and Mutant Ferlin C2 Domains von Davis, Dawn Belt, Doherty, Katherine R., Delmonte, Anthony J., McNally, Elizabeth M.

Volltext

Experimental and Theoretical Kinetic Isotope Effects for Asymmetric Dihydroxylation. Evidence Supporting a Rate-Limiting “(3 + 2)” Cycloaddition von DelMonte, Albert J, Haller, Jan, Houk, K. N, Sharpless, K. Barry, Singleton, Daniel A, Strassner, Thomas, Thomas, Allen A

Volltext

Normal myoblast fusion requires myoferlin von Doherty, Katherine R, Cave, Andrew, Davis, Dawn Belt, Delmonte, Anthony J, Posey, Avery, Earley, Judy U, Hadhazy, Michele, McNally, Elizabeth M

Volltext

Deuterium Kinetic Isotope Effects and the Mechanism of the Bacterial Luciferase Reaction von Francisco, Wilson A, Abu-Soud, Husam M, DelMonte, Albert J, Singleton, Daniel A, Baldwin, Thomas O, Raushel, Frank M

Volltext

Reinvestigation of the Isotope Effects for the Claisen and Aromatic Claisen Rearrangements:  The Nature of the Claisen Transition States von Meyer, Matthew P, DelMonte, Albert J, Singleton, Daniel A

Volltext

Gouvernements progressistes en Amérique latine (1998-2018): La fin d’un âge d’or

Volltext

Monnaies antiques monnaies des Pays-Bas méridionaux et Septentrionaux monnaies françaises et d'autres pays

Volltext bestellen

Monnaies antiques, monnaies des Pays-Bas, Monnaies françaises, méreaux. : 22 avril 1934 / Albert Delmonte

Volltext bestellen

Monnaies antiques monnaies des Pays-Bas monnaies françaises monnaies anglaises et d'autres pays médailles et jetons historiques

Volltext bestellen

Monnaies antiques Monnaies des Pays-Bas Monnaies françaises Monnaies anglaises

Volltext bestellen

Monnaies françaises, médailles françaises, monnaies d'or, livres mismatiques : 10 février 1934 / Albert Delmonte, expert

Volltext bestellen

Monnaies, médailles et jetons des Pays-Bas. Monnaies antiques,. Monnaies françaises. ?os 520

Volltext bestellen

Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer von Camidge, D. Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James Chih-Hsin, Han, Ji-Youn, Lee, Jong-Seok, Hochmair, Maximilian J, Li, Jacky Yu-Chung, Chang, Gee-Chen, Lee, Ki Hyeong, Gridelli, Cesare, Delmonte, Angelo, Garcia Campelo, Rosario, Kim, Dong-Wan, Bearz, Alessandra, Griesinger, Frank, Morabito, Alessandro, Felip, Enriqueta, Califano, Raffaele, Ghosh, Sharmistha, Spira, Alexander, Gettinger, Scott N, Tiseo, Marcello, Gupta, Neeraj, Haney, Jeff, Kerstein, David, Popat, Sanjay

Volltext

Dust-climate couplings over the past 800,000 years from the EPICA Dome C ice core von Lambert, F., Delmonte, B., Petit, J. R., Bigler, M., Kaufmann, P. R., Hutterli, M. A., Stocker, T. F., Ruth, U., Steffensen, J. P., Maggi, V.

Volltext

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors von Soria, J.-C., DeBraud, F., Bahleda, R., Adamo, B., Andre, F., Dientsmann, R., Delmonte, A., Cereda, R., Isaacson, J., Litten, J., Allen, A., Dubois, F., Saba, C., Robert, R., D'Incalci, M., Zucchetti, M., Camboni, M.G., Tabernero, J.

Volltext

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial von Camidge, D Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James C H, Han, Ji-Youn, Hochmair, Maximilian J, Lee, Ki Hyeong, Delmonte, Angelo, García Campelo, Maria Rosario, Kim, Dong-Wan, Griesinger, Frank, Felip, Enriqueta, Califano, Raffaele, Spira, Alexander, Gettinger, Scott N, Tiseo, Marcello, Lin, Huamao M, Gupta, Neeraj, Hanley, Michael J, Ni, Quanhong, Zhang, Pingkuan, Popat, Sanjay

Volltext

Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis von Papadimitrakopoulou, V.A., Mok, T.S., Han, J.-Y., Ahn, M.-J., Delmonte, A., Ramalingam, S.S., Kim, S.W., Shepherd, F.A., Laskin, J., He, Y., Akamatsu, H., Theelen, W.S.M.E., Su, W.-C., John, T., Sebastian, M., Mann, H., Miranda, M., Laus, G., Rukazenkov, Y., Wu, Y.-L.

Volltext

An immune-based biomarker signature is associated with mortality in COVID-19 patients von Abers, Michael S, Delmonte, Ottavia M, Ricotta, Emily E, Fintzi, Jonathan, Fink, Danielle L, de Jesus, Adriana A Almeida, Zarember, Kol A, Alehashemi, Sara, Oikonomou, Vasileios, Desai, Jigar V, Canna, Scott W, Shakoory, Bita, Dobbs, Kerry, Imberti, Luisa, Sottini, Alessandra, Quiros-Roldan, Eugenia, Castelli, Francesco, Rossi, Camillo, Brugnoni, Duilio, Biondi, Andrea, Bettini, Laura Rachele, D'Angio', Mariella, Bonfanti, Paolo, Castagnoli, Riccardo, Montagna, Daniela, Licari, Amelia, Marseglia, Gian Luigi, Gliniewicz, Emily F, Shaw, Elana, Kahle, Dana E, Rastegar, Andre T, Stack, Michael, Myint-Hpu, Katherine, Levinson, Susan L, DiNubile, Mark J, Chertow, Daniel W, Burbelo, Peter D, Cohen, Jeffrey I, Calvo, Katherine R, Tsang, John S, Su, Helen C, Gallin, John I, Kuhns, Douglas B, Goldbach-Mansky, Raphaela, Lionakis, Michail S, Notarangelo, Luigi D

Volltext

Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial von Camidge, D. Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James C.H., Han, Ji-Youn, Hochmair, Maximilian J., Lee, Ki Hyeong, Delmonte, Angelo, Garcia Campelo, Maria Rosario, Kim, Dong-Wan, Griesinger, Frank, Felip, Enriqueta, Califano, Raffaele, Spira, Alexander I., Gettinger, Scott N., Tiseo, Marcello, Lin, Huamao M., Liu, Yuyin, Vranceanu, Florin, Niu, Huifeng, Zhang, Pingkuan, Popat, Sanjay

Volltext